The Perils of Pull-Through
Listen on: Apple Podcasts or Spotify
In this episode of the IDI Podcast, Jack Timko, Senior Principal, Valuate Health Consultancy, discusses the perils of pull-through in market access and shares how data may be the answer.
Listen on: Apple Podcasts or Spotify
Archbow Consulting, Entrée Health, and Valuate Health Consultancy are sister companies under the Value and Access division of Omnicom Health Group. Learn more about our united organizations here.
For additional insights on this topic, you may also enjoy the following:
Archbow Consulting helps pharmaceutical and biotech companies in the USA and Europe design, build, and optimize product distribution and patient access strategies. Archbow was founded by industry veterans to meet a need in the marketplace for consulting options that offer diverse real-world experience, are able to leverage deep connections across the industry, and can also provide actionable strategic guidance. We invite you to learn more about our team, services, and clients’ success, and connect with us via email, LinkedIn or subscribing to this blog which you can do below.
Share in
Recent Posts
FDA Extends Compliance Deadline for Updated DSCSA Requirements
Understanding the revised timeline for compliance with specific updated DSCSA requirements
Are Direct-to-Patient Access Models the Future of Pharma?
Understanding the opportunity to sell directly to patients via a cash model
Key Takeaways from NASP 2024
The 2024 National Association of Specialty Pharmacy (NASP) conference showcased a landscape of rapid innovation and evolving industry trends.
SUBSCRIBE
Subscribe to receive news and updates from Archbow Consulting
|